Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Chemocentryx, Inc. (CCXI)
since 2014 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Chemocentryx, Inc..
Table 2 shows the detailed insider transactions.
This company's CIK number is 1340652.
Total stock buying since 2014: $822,817.
Total stock sales since 2014: $493,099,090.
Total stock option exercises since 2014: $39,017,290.
Table 3. Detailed insider trading at Chemocentryx, Inc. (CCXI)
Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
2022-08-16 | Kanaya Susan M (EVP, CFO and Sec.) | Sale | 19,898 | 50.95 | 1,013,803 |
2022-08-16 | Kanaya Susan M (EVP, CFO and Sec.) | Option Ex | 19,898 | 10.86 | 216,092 |
2022-08-04 | Schall Thomas J. (President and CEO) | Sale | 130,000 | 50.24 | 6,531,720 |
2022-08-04 | Schall Thomas J. (President and CEO) | Option Ex | 130,000 | 14.28 | 1,856,400 |
2022-08-04 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Sale | 7,564 | 50.22 | 379,864 |
2022-08-04 | Tyree James L (Director) | Sale | 10,000 | 50.22 | 502,200 |
2022-08-04 | Kanaya Susan M (EVP, CFO and Sec.) | Sale | 46,298 | 50.17 | 2,322,724 |
2022-08-04 | Kanaya Susan M (EVP, CFO and Sec.) | Option Ex | 46,298 | 6.42 | 297,464 |
2022-06-09 | Tyree James L (Director) | Sale | 3,863 | 25.94 | 100,190 |
2022-05-20 | Jain Rita (EVP, Chief Medical Officer) | Option Ex | 7,726 | .00 | 0 |
2022-05-20 | Parker Geoffrey M. (Director) | Option Ex | 7,726 | .00 | 0 |
2022-05-20 | Tyree James L (Director) | Option Ex | 7,726 | .00 | 0 |
2022-05-20 | Mckinnell Henry A (Director) | Option Ex | 7,726 | .00 | 0 |
2022-05-02 | Parker Geoffrey M. (Director) | Option Ex | 12,500 | 14.42 | 180,250 |
2022-03-27 | Jain Rita (EVP, Chief Medical Officer) | Option Ex | 5,251 | .00 | 0 |
2022-01-21 | Feczko Joseph M (Director) | Option Ex | 37,500 | 15.16 | 568,500 |
2022-01-01 | Schall Thomas J. (President and CEO) | Option Ex | 84,234 | .00 | 0 |
2022-01-01 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Option Ex | 20,934 | .00 | 0 |
2022-01-01 | Kanaya Susan M (EVP, CFO and Sec.) | Option Ex | 30,799 | .00 | 0 |
2021-12-17 | Tyree James L (Director) | Sale | 37,500 | 34.59 | 1,297,087 |
2021-12-17 | Tyree James L (Director) | Option Ex | 37,500 | 13.52 | 507,000 |
2021-12-01 | Schall Thomas J. (President and CEO) | Option Ex | 45,936 | 12.29 | 564,553 |
2021-10-12 | Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) | Sale | 4,000,000 | 39.43 | 157,720,000 |
2021-05-07 | Butt Tausif (EVP, Chief Operating Officer) | Buy | 10,870 | 11.06 | 120,243 |
2021-03-27 | Jain Rita (Director) | Option Ex | 5,251 | .00 | 0 |
2021-03-05 | Parker Geoffrey M. (Director) | Sale | 30,000 | 56.33 | 1,689,990 |
2021-03-04 | Parker Geoffrey M. (Director) | Sale | 1,910 | 60.20 | 114,980 |
2021-03-02 | Edwards Thomas A. (Director) | Sale | 1,100 | 70.06 | 77,060 |
2021-03-01 | Kwan Pui San (Principal Acctg Officer) | Sale | 3,347 | 68.48 | 229,219 |
2021-03-01 | Kwan Pui San (Principal Acctg Officer) | Option Ex | 3,347 | 10.31 | 34,497 |
2021-03-01 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Sale | 33,092 | 68.43 | 2,264,386 |
2021-03-01 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Option Ex | 33,092 | 9.50 | 314,374 |
2021-02-09 | Edwards Thomas A. (Director) | Sale | 400 | 70.03 | 28,014 |
2021-02-09 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Sale | 700 | 69.66 | 48,764 |
2021-02-09 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Option Ex | 700 | 11.02 | 7,714 |
2021-02-08 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Sale | 7,420 | 67.64 | 501,881 |
2021-02-08 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Option Ex | 7,420 | 11.02 | 81,768 |
2021-02-05 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Sale | 805 | 67.07 | 53,994 |
2021-02-05 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Option Ex | 805 | 11.02 | 8,871 |
2021-02-04 | Kwan Pui San (Principal Acctg Officer) | Sale | 3,347 | 65.00 | 217,555 |
2021-02-04 | Kwan Pui San (Principal Acctg Officer) | Option Ex | 3,347 | 10.31 | 34,497 |
2021-02-04 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Sale | 1,400 | 67.14 | 93,994 |
2021-02-04 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Option Ex | 1,400 | 11.02 | 15,428 |
2021-02-02 | Edwards Thomas A. (Director) | Sale | 20,000 | 61.00 | 1,220,020 |
2021-01-25 | Kwan Pui San (Principal Acctg Officer) | Sale | 4,184 | 65.00 | 271,960 |
2021-01-25 | Kwan Pui San (Principal Acctg Officer) | Option Ex | 4,184 | 9.38 | 39,266 |
2021-01-25 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Sale | 1,375 | 67.03 | 92,171 |
2021-01-25 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Option Ex | 1,375 | 11.02 | 15,152 |
2021-01-01 | Schall Thomas J. (President and CEO) | Option Ex | 87,899 | .00 | 0 |
2021-01-01 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Option Ex | 21,100 | .00 | 0 |
2021-01-01 | Kanaya Susan M (EVP, CFO and Sec.) | Option Ex | 30,333 | .00 | 0 |
2020-12-28 | Edwards Thomas A. (Director) | Sale | 10,782 | 61.50 | 663,093 |
2020-12-24 | Edwards Thomas A. (Director) | Sale | 14,218 | 61.18 | 869,899 |
2020-12-15 | Kwan Pui San (Principal Acctg Officer) | Sale | 42,593 | 65.06 | 2,771,228 |
2020-12-15 | Kwan Pui San (Principal Acctg Officer) | Option Ex | 42,593 | 9.38 | 399,735 |
2020-12-15 | Schall Thomas J. (President and CEO) | Sale | 17,619 | 65.01 | 1,145,446 |
2020-12-15 | Schall Thomas J. (President and CEO) | Option Ex | 17,619 | 14.31 | 252,127 |
2020-12-14 | Kwan Pui San (Principal Acctg Officer) | Sale | 8,957 | 65.02 | 582,402 |
2020-12-14 | Kwan Pui San (Principal Acctg Officer) | Option Ex | 8,957 | 7.07 | 63,325 |
2020-12-14 | Schall Thomas J. (President and CEO) | Sale | 11,153 | 65.03 | 725,246 |
2020-12-14 | Schall Thomas J. (President and CEO) | Option Ex | 11,153 | 14.31 | 159,599 |
2020-08-03 | Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) | Sale | 49,258 | 53.71 | 2,645,450 |
2020-07-31 | Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) | Sale | 40,402 | 52.88 | 2,136,417 |
2020-07-30 | Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) | Sale | 48,081 | 54.22 | 2,606,807 |
2020-07-29 | Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) | Sale | 88,012 | 52.45 | 4,616,405 |
2020-07-28 | Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) | Sale | 40,160 | 53.78 | 2,159,804 |
2020-07-27 | Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) | Sale | 34,236 | 53.41 | 1,828,578 |
2020-07-24 | Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) | Sale | 26,050 | 52.92 | 1,378,487 |
2020-07-23 | Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) | Sale | 34,555 | 55.00 | 1,900,594 |
2020-07-22 | Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) | Sale | 72,469 | 55.65 | 4,032,899 |
2020-07-21 | Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) | Sale | 87,529 | 55.82 | 4,885,956 |
2020-07-20 | Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) | Sale | 54,598 | 55.94 | 3,054,157 |
2020-07-17 | Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) | Sale | 47,890 | 56.28 | 2,695,297 |
2020-07-16 | Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) | Sale | 73,500 | 57.33 | 4,213,975 |
2020-07-15 | Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) | Sale | 86,298 | 59.04 | 5,094,775 |
2020-07-14 | Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) | Sale | 100,000 | 57.90 | 5,789,700 |
2020-07-13 | Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) | Sale | 100,000 | 58.77 | 5,876,800 |
2020-07-10 | Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) | Sale | 45,844 | 60.05 | 2,752,748 |
2020-07-09 | Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) | Sale | 100,000 | 60.73 | 6,073,100 |
2020-07-08 | Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) | Sale | 100,000 | 60.28 | 6,028,500 |
2020-07-07 | Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) | Sale | 79,387 | 58.88 | 4,674,544 |
2020-07-06 | Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) | Sale | 86,690 | 58.74 | 5,092,257 |
2020-07-02 | Vifor Fresenius Medical Care Renal Pharma Ltd. (10% Owner) | Sale | 87,781 | 57.28 | 5,027,832 |
2020-06-15 | Schall Thomas J. (President and CEO) | Sale | 2,000 | 65.05 | 130,090 |
2020-06-15 | Schall Thomas J. (President and CEO) | Option Ex | 2,000 | 14.31 | 28,620 |
2020-06-12 | Schall Thomas J. (President and CEO) | Sale | 88,753 | 65.08 | 5,775,867 |
2020-06-12 | Schall Thomas J. (President and CEO) | Option Ex | 88,753 | 14.31 | 1,270,055 |
2020-06-12 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Sale | 33,541 | 65.10 | 2,183,519 |
2020-06-12 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Option Ex | 33,541 | 10.86 | 364,255 |
2020-06-12 | Kanaya Susan M (EVP, CFO and Sec.) | Sale | 50,000 | 64.58 | 3,229,050 |
2020-06-12 | Kanaya Susan M (EVP, CFO and Sec.) | Option Ex | 50,000 | 9.61 | 480,250 |
2020-06-03 | Kanaya Susan M (EVP, CFO and Sec.) | Option Ex | 10,750 | 5.47 | 58,834 |
2020-05-26 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Sale | 19,612 | 60.34 | 1,183,427 |
2020-05-26 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Option Ex | 19,612 | 6.62 | 129,831 |
2020-05-23 | Parker Geoffrey M. (Director) | Option Ex | 7,724 | .00 | 0 |
2020-05-23 | Tyree James L (Director) | Option Ex | 7,724 | .00 | 0 |
2020-05-22 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Sale | 40,867 | 60.06 | 2,454,512 |
2020-05-22 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Option Ex | 40,867 | 6.62 | 270,539 |
2020-05-21 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Sale | 2,800 | 59.99 | 167,986 |
2020-05-21 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Option Ex | 2,800 | 6.62 | 18,536 |
2020-05-12 | Schall Thomas J. (President and CEO) | Sale | 35,865 | 57.75 | 2,071,096 |
2020-05-12 | Schall Thomas J. (President and CEO) | Option Ex | 35,865 | 14.31 | 513,228 |
2020-05-11 | Schall Thomas J. (President and CEO) | Sale | 70,608 | 55.73 | 3,935,336 |
2020-05-11 | Schall Thomas J. (President and CEO) | Option Ex | 70,608 | 14.31 | 1,010,400 |
2020-05-11 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Sale | 34,222 | 55.12 | 1,886,145 |
2020-05-11 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Option Ex | 34,222 | 3.57 | 122,172 |
2020-05-08 | Schall Thomas J. (President and CEO) | Sale | 4,201 | 55.01 | 231,113 |
2020-05-08 | Schall Thomas J. (President and CEO) | Option Ex | 4,201 | 14.31 | 60,116 |
2020-05-08 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Sale | 4,312 | 50.01 | 215,638 |
2020-05-08 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Option Ex | 4,312 | 3.57 | 15,393 |
2020-05-05 | Schall Thomas J. (President and CEO) | Sale | 8,851 | 55.01 | 486,849 |
2020-05-05 | Schall Thomas J. (President and CEO) | Option Ex | 8,851 | 14.31 | 126,657 |
2020-05-05 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Sale | 8,860 | 55.01 | 487,344 |
2020-05-05 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Option Ex | 8,860 | 3.57 | 31,630 |
2020-05-05 | Kanaya Susan M (EVP, CFO and Sec.) | Sale | 20,123 | 54.73 | 1,101,231 |
2020-05-05 | Kanaya Susan M (EVP, CFO and Sec.) | Option Ex | 20,123 | 8.19 | 164,807 |
2020-05-04 | Kanaya Susan M (EVP, CFO and Sec.) | Sale | 54,877 | 54.57 | 2,994,802 |
2020-05-04 | Kanaya Susan M (EVP, CFO and Sec.) | Option Ex | 54,877 | 8.19 | 449,442 |
2020-03-27 | Jain Rita (Director) | Option Ex | 5,251 | .00 | 0 |
2020-03-23 | Parker Geoffrey M. (Director) | Sale | 30,000 | 36.41 | 1,092,450 |
2020-03-04 | Schall Thomas J. (President and CEO) | Sale | 40,844 | 50.35 | 2,056,699 |
2020-03-04 | Schall Thomas J. (President and CEO) | Option Ex | 40,844 | 14.31 | 584,477 |
2020-02-20 | Schall Thomas J. (President and CEO) | Sale | 15,341 | 50.66 | 777,098 |
2020-02-20 | Schall Thomas J. (President and CEO) | Option Ex | 15,341 | 14.31 | 219,529 |
2020-02-19 | Schall Thomas J. (President and CEO) | Sale | 63,340 | 50.77 | 3,216,088 |
2020-02-19 | Schall Thomas J. (President and CEO) | Option Ex | 63,340 | 14.31 | 906,395 |
2020-02-19 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Sale | 42,631 | 50.67 | 2,159,942 |
2020-02-19 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Option Ex | 42,631 | 8.19 | 349,147 |
2020-02-19 | Kanaya Susan M (EVP, CFO and Sec.) | Sale | 24,200 | 50.34 | 1,218,300 |
2020-02-19 | Kanaya Susan M (EVP, CFO and Sec.) | Option Ex | 24,200 | 10.86 | 262,812 |
2020-02-13 | Kanaya Susan M (EVP, CFO and Sec.) | Sale | 45,300 | 49.61 | 2,247,151 |
2020-02-13 | Kanaya Susan M (EVP, CFO and Sec.) | Option Ex | 45,300 | 9.53 | 431,482 |
2020-02-12 | Kanaya Susan M (EVP, CFO and Sec.) | Sale | 2,500 | 49.51 | 123,775 |
2020-02-12 | Kanaya Susan M (EVP, CFO and Sec.) | Option Ex | 2,500 | 9.53 | 23,812 |
2020-02-11 | Kwan Pui San (Principal Acctg Officer) | Sale | 18,941 | 49.15 | 930,893 |
2020-02-11 | Kanaya Susan M (EVP, CFO and Sec.) | Sale | 3,000 | 49.50 | 148,509 |
2020-02-11 | Kanaya Susan M (EVP, CFO and Sec.) | Option Ex | 3,000 | 9.53 | 28,575 |
2020-02-06 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Sale | 36,850 | 47.31 | 1,743,336 |
2020-02-06 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Option Ex | 36,850 | 8.19 | 301,801 |
2020-02-05 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Sale | 13,150 | 47.03 | 618,457 |
2020-02-05 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Option Ex | 13,150 | 8.19 | 107,698 |
2020-02-04 | Schall Thomas J. (President and CEO) | Sale | 119,525 | 45.19 | 5,400,737 |
2020-02-04 | Schall Thomas J. (President and CEO) | Option Ex | 119,525 | 14.31 | 1,710,402 |
2020-02-04 | Kanaya Susan M (EVP, CFO and Sec.) | Sale | 99,617 | 45.09 | 4,492,228 |
2020-02-04 | Kanaya Susan M (EVP, CFO and Sec.) | Option Ex | 99,617 | 14.31 | 1,425,519 |
2020-02-03 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Sale | 48,471 | 44.47 | 2,155,505 |
2020-02-03 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Option Ex | 48,471 | 8.19 | 396,977 |
2020-02-03 | Kanaya Susan M (EVP, CFO and Sec.) | Sale | 3,837 | 44.91 | 172,315 |
2020-02-03 | Kanaya Susan M (EVP, CFO and Sec.) | Option Ex | 3,837 | 14.31 | 54,907 |
2020-01-21 | Cappel Markus J. (Chief Bus. Officer & Treasurer) | Sale | 1,259 | 44.00 | 55,392 |
Insider trading activities including stock purchases, stock sales, and option exercises
of CCXI listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Chemocentryx, Inc. (symbol CCXI,
CIK number 1340652) see
the Securities and Exchange Commission (SEC) website.